ReviewHealth affairs scholar2026
Standardized clinical assessment and management plans revisited: lessons learned from a decade of implementation.
Review in Health affairs scholar, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Originally introduced in Methods: We conducted a structured historical review of more than 40 peer-reviewed publications describing SCAMPs development, implementation, evaluation, and iterative refinement. The review synthesizes reported experiences across clinical domains, settings, and study designs, and is intended as a descriptive, perspective-oriented assessment rather than a formal systematic review. Results: Published SCAMPs reports describe broad deployment across diverse conditions and institutions, with recurrent findings of reduced practice variation, changes in resource utilization, iterative pathway refinement, and high reported adherence among participating clinicians. The literature also reflects important limitations, including heterogeneity of study designs, limited evaluation of harms, equity, patient-reported outcomes, and implementation burden, and likely underrepresentation of unsuccessful implementations. Early reliance on paper-based workflows constrained scalability and consistency of use. Conclusion: This perspective synthesizes the published SCAMPs experience, highlighting reported benefits alongside implementation conditions, risks, and limitations. SCAMPs are best understood as a clinician-led methodology whose value is conditional on governance, analytic capacity, patient safety oversight, and attention to equity. Emerging informatics standards and artificial intelligence tools may enhance scalability and learning, but require careful governance to avoid amplifying bias or harm.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.